TRAX NASDAQ
First Tracks Biotherapeutics Inc
1W: +14.0%
1M: +156.8%
3M: +131.4%
YTD: +121.2%
$41.85
-0.18 (-0.43%)
Weekly Expected Move ±30.0%
$14
$25
$36
$46
$57
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.5B
52W Range14.72-46.45
Volume760,613
Avg Volume674,443
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel R. Faga
Employees104
SectorHealthcare
IndustryBiotechnology
IPO Date2026-04-20
Websitefirsttracksbio.com
10770 Wateridge Circle
San Diego, CA 92121
US
San Diego, CA 92121
US
858 362 6295
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Latest News
First Tracks Biotherapeutics Ord Shs (TRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TRAX Stock Volatile As Traders Focus On Cash And Momentum - StocksToTrade
First Tracks Biotherapeutics Ord Shs (TRAX) Cash Flow - TradingKey
First Tracks Biotherapeutics Ord Shs (TRAX) Income Statement - TradingKey
Palms Trax shares first new single in five years, ‘Soft Trance, Hard Gossip’: Listen - DJ Mag
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| ANAPTYSBIO, INC | J-Other | 100 | — | 2026-04-20 |
| ANAPTYSBIO, INC | 0 | — | 2026-04-01 |